QNT Stock Q2 2026: Quantinuum Earnings - The Bull Case Is Already The Price

Quantinuum Inc (QNT) Q2 2026 — The results 8-K cleared EDGAR at 8:11pm ET on Monday August 11 - well AFTER the close, so Tuesday August 12 was the reaction session: the shares opened USD59.65 against a USD56.06 prior close, traded as high as USD72.40 and closed USD71.74. That is plus 27.97 pct on 4,584,200 shares, 3.45x the 20-session average, and it never traded back below Monday's close. By August 17 they were USD66.01. Quantinuum is the trapped-ion quantum computing company spun out of Honeywell. It priced its IPO at USD60.00 on June 5, 2026, so this is the FIRST quarter it has ever reported to a public market. Q2 revenue was USD7.998M, up 279.4 pct against a USD2.108M base quarter, with adjusted gross margin at 61.7 pct and USD2.107bn of cash against no debt. The shares rose 27.97 pct on the print. THE CALL: AVOID (3/5, MEDIUM - A REAL COMPANY, AT THE PRICE OF A CERTAINTY) — base-case value ~$26.56 vs ~$66.01 today. KEY METRICS: - CALL: AVOID, 3/5. Fair value USD26.56 against the USD66.01 close, minus 59.8 pct. Bear USD5.87 / base USD18.59 / bull USD65.71, weighted 30/45/25 across three 2030 revenue outcomes, each at a terminal sales multiple and discounted 4.5 years at 15 pct. - THE ANGLE: the bull case IS the price. Take the lowest target on the Street - Morgan Stanley's, at USD78 - and its own published model of 12x USD2.5bn of 2030 revenue. Discount that to TODAY instead of to 2027 and it is USD65.71 a share. The stock closed USD66.01. - WHAT THE PRICE ASSUMES: USD263.3M as-converted shares at USD66.01 is a USD17.38bn market value, less USD2.107bn of cash equals USD15.27bn of enterprise value. That is 509x the USD28-32M of revenue the company guides to for all of 2026. - THE SANITY CHECK: justifying today's enterprise value at 12x terminal sales needs USD2,387M of 2030 revenue - 164 pct growth a year for 4.5 years. BCG sizes the ENTIRE 2030 quantum provider market at USD1-2bn; BCC Research says USD7.3bn. - THE LOSS IS NOT WHAT IT LOOKS LIKE: GAAP net loss was USD596.520M, but USD464.587M is equity compensation vesting at the listing and USD47.615M is a non-cash warrant mark. 87.7 pct is non-cash or one-off. Adjusted EBITDA was minus USD68.310M. - THE COMP CUTS BOTH WAYS: revenue grew 279 pct off a USD2.108M trough, yet SIX-MONTH revenue FELL 37.6 pct, USD13.235M vs USD21.193M. Strip 2025's one-off USD16.526M lease sale and the recurring line is up 167 pct - that is the real number. - THE GUIDANCE NOBODY QUOTES: first formal guidance is USD28-32M, a USD30.0M midpoint against FY2025 revenue of USD30.931M. Flat to down on the total; roughly double the FY2025 recurring line of USD14.780M; and only 29 pct above FY2024's USD23.256M. What to watch: UP: a 2027 revenue range starting with a six or a seven rather than a three or a four, which moves the base case onto a different track entirely; or the Sol machine landing on schedule in 2027, which raises the odds on Apollo in 2029 where all the value sits. DOWN: contracted backlog converting slower than the 39.6 pct of USD74.2M the company schedules for the next twelve months, or any slip in the Apollo date. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.